Click to Share

Filter News
Show All Results
News By Country
News By Tag
Gene Therapy Remove

October 2019

Public Company News

Business Press Releases

Gene Therapy Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Partners4Access
PARTNERS4ACCESS has announced the appointment of Akshay Kumar as Partner to lead its rapidly expanding global strategic market access team.
By Project Alive
Grass-roots group raises $2.35 million through community events
By Mathew Forbes Romer Foundation
S. Florida-Based Organization and Its Supporters Honor Those Who Have Helped Drive Therapy Breakthroughs Together
By Partners4Access
Partners4Access has announced their gold sponsorship of the biotech industry conference World Orphan Drug Congress (WODC) USA. The event will take place at The Gaylord National Harbor Hotel in Oxon Hill, Maryland between April 10-12, 2019.
By Partners4Access
Sophie Schmitz, Managing Partner of Partners4Access is to lead two educational sessions on gene therapy at the Academy of Managed Care Pharmacy (AMCP)'s annual meeting between March 25-28, 2019.
By Guide Therapeutics, Inc.
GreatPoint Ventures, a leading San Francisco based venture capital firm, announced the closing of an investment in Guide Therapeutics, Inc. (GuideRx), a developer of lipid nanoparticles (LNPs) for delivery of therapeutics for gene therapy.
By Mathew Forbes Romer Foundation
S. Florida-Based Organization Hosts Annual "Sweetness and Laughter" Gala & "See the Light" Awards Ceremony March 16th in Delray Beach
By SMi Group
SMi Group are delighted to welcome expertise from a senior panel of big pharma and biotech organisations and regulatory bodies, at the most talked about conference on Cell & Gene Therapy 2018 launching this October in the City of London, UK.
By SMi Group
The lengthening shadow of increase in health spending in the coming years is sharpening the minds of legislators, regulators and payers alike.
By Partners4Access
As part of its business expansion activities, Partners4Access' Sophie Schmitz will be attending industry group, BioIndustry Association (BIA)'s Summer Networking Reception on Thursday, July 12.
By Aldevron
Aldevron, a leading global provider of plasmid DNA and mRNA manufacturing, protein production and antibody discovery services, and Odylia, a nonprofit organization working to develop treatments for ultra-rare ocular diseases using gene therapy, have...
By Project Alive
Donation in honor of Hunter Syndrome advocate Simon Ibell who passed away in 2017 at the age of 39 due to complications from Hunter Syndrome
By Partners4Access
Free webinar will be held on Wednesday April 4 2018 at 17:00 GMT/1200 EST/9:00 PST.
By RNCOS E-Services Pvt. Ltd.
RNCOS has recently added a new Market Research Report titled, "Global & US Gene Therapy Market Forecast to 2020" to its report gallery. This report provides extensive research on Global & US Gene Therapy Market.
By Maxygen LLC
The new Maxygen brings together scientists experienced in the application of molecular breeding paired with an accomplished leader in contract manufacturing to offer custom directed evolution programs across all sectors of biotech.
By Project Alive
Vector Production and Active IND Meet Major Milestones in Foundation-Scientists Collaboration to Develop an Experimental Therapy for Young Boys with a Rare Dementia-Like Disease
By Mary Ann Liebert, Inc., publishers
As a gene therapy cure for hemophilia A moves closer to reality, a new study sheds light on a challenging complication in which a host autoimmune response inhibits the production of normal clotting factor VIII from the transferred FVIII gene.
By Project Alive
Families Are Making A Cure A Reality for the Rare Disease Hunter Syndrome / MPS II
By Partners4Access
Partners4Access (P4A), the specialists in orphan drug access, are launching a weekly newsletter focussing on key developments in the rare diseases and orphan drugs market access landscape.
By Partners4Access
Sophie Schmitz, Managing Partner of Partners4Access, the specialists in orphan drug access, is presenting at the 8th annual meeting of the World Orphan Drug Congress in Barcelona on November 15, 2017 on Gene Therapy.
By Partners4Access
Partners4Access (P4A) the specialists in orphan drug access, are presenting 3 posters at the International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) 20th European Congress in Glasgow from 4th to 8th November 2017.

Page: 1 Page updated every 10 minutes

Like PRLog?
Click to Share